down arrow

Jagsonpal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
214.00
12.1 (5.99%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

205.40215.00

52 Week

109.42328.02
Valuation
Technical
Day's Volume

CASH

1.22 lacs (26.05%) Volume

Shareholding (Dec 2024)

FII

2.10%

Held by 14 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

67.81%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

With a growth in Net Profit of 179.14%, the company declared Very Positive results in Dec 24

3

Stock is technically in a Mildly Bullish range

4

With ROE of 18.1, it has a Very Expensive valuation with a 6.8 Price to Book Value

5

Despite the size of the company, domestic mutual funds hold only 0% of the company

6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,421 Cr (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.99%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

18.07%

stock-summary
Price to Book

6.80

Revenue and Profits (1 Year):
Net Sales:
74 Cr
(Quarterly Results - Dec 2024)
Net Profit:
32 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.99%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
13.73%
0%
13.73%
1 Year
80.53%
3.42%
83.95%
2 Years
53.56%
3.81%
57.37%
3 Years
56.82%
4.51%
61.33%
4 Years
541.87%
26.12%
567.99%
5 Years
2083.67%
106.71%
2190.38%

Latest dividend: 5 per share ex-dividend date: Sep-06-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.66%
EBIT Growth (5y)
32.18%
EBIT to Interest (avg)
26.48
Debt to EBITDA (avg)
0.39
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.37
Tax Ratio
20.34%
Dividend Payout Ratio
58.85%
Pledged Shares
0
Institutional Holding
2.10%
ROCE (avg)
30.44%
ROE (avg)
14.53%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
33
Price to Book Value
6.80
EV to EBIT
32.78
EV to EBITDA
28.26
EV to Capital Employed
9.86
EV to Sales
5.02
PEG Ratio
0.86
Dividend Yield
0.99%
ROCE (Latest)
21.97%
ROE (Latest)
18.07%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 14 FIIs (2.1%)

Promoter with highest holding

Aresko Progressive Private Limited (20.09%)

Highest Public shareholder

Authum Investment And Infrastructure Limited (1.46%)

Individual Investors Holdings

20.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.88% vs 21.57% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 179.14% vs 115.01% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.03",
          "val2": "74.69",
          "chgp": "-0.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.84",
          "val2": "16.28",
          "chgp": "-2.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.23",
          "chgp": "13.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "23.18",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "31.99",
          "val2": "11.46",
          "chgp": "179.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.40%",
          "val2": "21.80%",
          "chgp": "-0.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.13",
          "val2": "117.98",
          "chgp": "15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.52",
          "val2": "17.00",
          "chgp": "56.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.44",
          "val2": "0.37",
          "chgp": "18.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.29",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.79",
          "val2": "14.95",
          "chgp": "12.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.48%",
          "val2": "14.41%",
          "chgp": "5.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 27.21% vs -8.85% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 157.96% vs -10.46% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.16",
          "val2": "165.21",
          "chgp": "27.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.36",
          "val2": "20.39",
          "chgp": "107.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "19.89",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "48.78",
          "val2": "18.91",
          "chgp": "157.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.16%",
          "val2": "12.34%",
          "chgp": "7.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -15.94% vs 41.68% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "208.70",
          "val2": "236.71",
          "chgp": "-11.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.06",
          "val2": "34.15",
          "chgp": "-32.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.81",
          "val2": "0.41",
          "chgp": "97.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.46",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "22.46",
          "val2": "26.72",
          "chgp": "-15.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.05%",
          "val2": "14.43%",
          "chgp": "-3.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
74.03
74.69
-0.88%
Operating Profit (PBDIT) excl Other Income
15.84
16.28
-2.70%
Interest
0.26
0.23
13.04%
Exceptional Items
23.18
0.00
Standalone Net Profit
31.99
11.46
179.14%
Operating Profit Margin (Excl OI)
21.40%
21.80%
-0.40%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.88% vs 21.57% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 179.14% vs 115.01% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
136.13
117.98
15.38%
Operating Profit (PBDIT) excl Other Income
26.52
17.00
56.00%
Interest
0.44
0.37
18.92%
Exceptional Items
-3.29
0.00
Standalone Net Profit
16.79
14.95
12.31%
Operating Profit Margin (Excl OI)
19.48%
14.41%
5.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 15.38% vs -2.59% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 12.31% vs 12.15% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
210.16
165.21
27.21%
Operating Profit (PBDIT) excl Other Income
42.36
20.39
107.75%
Interest
0.70
0.60
16.67%
Exceptional Items
19.89
0.00
Standalone Net Profit
48.78
18.91
157.96%
Operating Profit Margin (Excl OI)
20.16%
12.34%
7.82%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 27.21% vs -8.85% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 157.96% vs -10.46% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
208.70
236.71
-11.83%
Operating Profit (PBDIT) excl Other Income
23.06
34.15
-32.47%
Interest
0.81
0.41
97.56%
Exceptional Items
0.00
-3.46
100.00%
Standalone Net Profit
22.46
26.72
-15.94%
Operating Profit Margin (Excl OI)
11.05%
14.43%
-3.38%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -15.94% vs 41.68% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Jagsonpal Pharmaceuticals Ltd stock-summary
stock-summary
Jagsonpal Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.
Company Coordinates stock-summary
Company Details
T-210 J, Shahpur Jat New Delhi New Delhi : 110049
stock-summary
Tel: 91-011-46181100/46109900
stock-summary
http://www.jagsonpal.com
stock-summary
nandita.singh@jagsonpal.com
Registrar Details
MCS Ltd , F-65, , Okhla Industrial Area, Phase - I, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."